KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Cash from Operations (2018 - 2025)

Historic Cash from Operations for Moderna (MRNA) over the last 8 years, with Q3 2025 value amounting to -$847.0 million.

  • Moderna's Cash from Operations rose 4591.32% to -$847.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 billion, marking a year-over-year increase of 3832.24%. This contributed to the annual value of -$3.0 billion for FY2024, which is 365.62% up from last year.
  • According to the latest figures from Q3 2025, Moderna's Cash from Operations is -$847.0 million, which was up 4591.32% from -$919.0 million recorded in Q2 2025.
  • Over the past 5 years, Moderna's Cash from Operations peaked at $4.1 billion during Q2 2021, and registered a low of -$1.6 billion during Q3 2023.
  • In the last 5 years, Moderna's Cash from Operations had a median value of $252.0 million in 2022 and averaged $509.3 million.
  • In the last 5 years, Moderna's Cash from Operations surged by 1702916.67% in 2021 and then tumbled by 73492.06% in 2023.
  • Quarter analysis of 5 years shows Moderna's Cash from Operations stood at $3.3 billion in 2021, then crashed by 49.79% to $1.7 billion in 2022, then plummeted by 62.58% to $622.0 million in 2023, then soared by 32.64% to $825.0 million in 2024, then crashed by 202.67% to -$847.0 million in 2025.
  • Its Cash from Operations stands at -$847.0 million for Q3 2025, versus -$919.0 million for Q2 2025 and -$1.0 billion for Q1 2025.